Investing.com
Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance ’against’
📉
AI Sentiment
Negative
3/10
- Home
- ALC
ALC
Alcon Inc.
as of 12-12-2025 3:55pm EST
$78.74
$0.03
-0.03%
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Chart Type:
Time Range:
| Founded: | 1945 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 38.7B | IPO Year: | N/A |
| Target Price: | $88.71 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 2.10 | EPS Growth: | -10.23 |
| 52 Week Low/High: | $71.55 - $99.20 | Next Earning Date: | 11-11-2025 |
| Revenue: | $10,185,000,000 | Revenue Growth: | 4.34% |
| Revenue Growth (this year): | 5.79% | Revenue Growth (next year): | 7.36% |
AI-Powered ALC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 77.42%
77.42%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Alcon Inc. News
ALC Breaking Stock News: Dive into ALC Ticker-Specific Updates for Smart Investing
Business Wire
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon
📉
AI Sentiment
Negative
2/10
Investing.com
STAAR Surgical accuses activist Broadwood of ’misinformation campaign’
📉
AI Sentiment
Negative
3/10
MT Newswires
Sector Update: Health Care Stocks Advance Late Afternoon
📊
AI Sentiment
Positive
7/10
GuruFocus.com
Alcon Just Got Hit With Its First Bearish Call Since August
📉
AI Sentiment
Negative
2/10
MT Newswires
STAAR Surgical Says No 'Credible Buyer' During Go-Shop Process in Alcon Deal
âž–
AI Sentiment
Neutral
5/10
Compare ALC vs Leading Stocks
See how ALC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ALC Alcon Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.